Multi-center Randomized Controlled Clinical Study of Shenling Baishu Granule to Prevent the Recurrence of Low-risk Colorectal Adenoma

Recruiting now · Phase 4

Conditions studied: Low-risk Colorectal Adenoma

In brief

1. Complete a large-sample, multicenter, randomized blank-controlled clinical trial to evaluate Shenling Baizhu Granules for the prevention of colorectal adenoma recurrence. 2. Generate high-level, internationally recognized clinical evidence to support the development of clinical practice guidelines for the prevention and treatment of colorectal adenoma using traditional Chinese medicine, and to strengthen the recommendation level of Shenling Baizhu Granules in clinical guidelines. 3. Define the clinical characteristics of patient subgroups most likely to benefit from Shenling Baizhu Granules for preventing colorectal adenoma recurrence.

Key facts

Study ID

NCT06930157

Run by

Shanghai Jiao Tong University School of Medicine

People needed

624

Starts

2025-11-24

Expected to finish

2028-12-31

Last updated by the study team

2026-01-28

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meets the diagnostic criteria for low-risk colorectal adenoma.
• Has undergone a colonoscopy of adequate quality (adequate bowel preparation, cecal intubation achieved, and withdrawal time ≥6 minutes) and received endoscopic minimally invasive polypectomy.
• Within 3 months after adenoma resection.
• 18-70 years of age; any sex.
• Willing to participate and has voluntarily provided written informed consent.

You may not qualify if…

• Incomplete adenoma resection.
• Long-term use of aspirin, folic acid, calcium supplements, vitamin D, or similar agents.
• Known hereditary polyposis syndromes (e.g., familial adenomatous polyposis) or hereditary colorectal cancer syndromes (e.g., Lynch syndrome/hereditary nonpolyposis colorectal cancer).
• Colonoscopy findings strongly suggestive of inflammatory bowel disease.
• History of malignancy within the past 5 years.
• Pregnant or breastfeeding women, or participants with pregnancy potential who are planning pregnancy.
• Severe cardiovascular or cerebrovascular disease, hepatic or renal insufficiency, or diabetes mellitus.
• Severe psychiatric disorders that would preclude cooperation with colonoscopy procedures.
• Current condition preventing oral administration of the study drug (e.g., dysphagia, chronic diarrhea, intestinal obstruction).
• Participation in another clinical study within the past 3 months or current participation in another clinical study.
• Any other condition that, in the investigator's judgment, makes the participant unsuitable for enrollment.

Where it is running

• Renji Hospital — Shanghai, Shanghai Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.